Trademark: 97197252
Word
YORVIPATH
Status
Registered
Status Code
700
Status Date
Tuesday, July 4, 2023
Serial Number
97197252
Registration Number
7096561
Registration Date
Tuesday, July 4, 2023
Mark Type
4000
Filing Date
Thursday, December 30, 2021
Published for Opposition
Tuesday, April 18, 2023

Trademark Owner History

Classifications
9 Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders
5 Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders
10 Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers with integrated recorded software featuring web-based medical information collected via said apparatus for physical and psychological examination and assessment of patients remotely and at a clinic, sold as a unit; dosage management dispensers with integrated recorded software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic, namely, pen-type syringes and injection devices for administering drugs, sold as a unit

Trademark Events
Jul 4, 2023
Notice Of Registration Confirmation Emailed
Jul 4, 2023
Registered-Principal Register
Apr 18, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 18, 2023
Published For Opposition
Mar 29, 2023
Notification Of Notice Of Publication E-Mailed
Mar 15, 2023
Approved For Pub - Principal Register
Mar 14, 2023
Examiner's Amendment Entered
Mar 14, 2023
Notification Of Examiners Amendment E-Mailed
Mar 14, 2023
Examiners Amendment E-Mailed
Mar 14, 2023
Examiners Amendment -Written
Mar 2, 2023
Teas/Email Correspondence Entered
Mar 2, 2023
Correspondence Received In Law Office
Mar 1, 2023
Assigned To Lie
Dec 19, 2022
Teas Response To Suspension Inquiry Received
Dec 19, 2022
Notification Of Letter Of Suspension E-Mailed
Dec 19, 2022
Letter Of Suspension E-Mailed
Dec 19, 2022
Suspension Letter Written
Dec 7, 2022
Assigned To Examiner
Nov 30, 2022
Teas/Email Correspondence Entered
Nov 30, 2022
Correspondence Received In Law Office
Nov 30, 2022
Teas Response To Office Action Received
Jul 29, 2022
Assigned To Examiner
Jun 2, 2022
Notification Of Non-Final Action E-Mailed
Jun 2, 2022
Non-Final Action E-Mailed
Jun 2, 2022
Non-Final Action Written
May 23, 2022
Assigned To Examiner
Jan 5, 2022
New Application Office Supplied Data Entered
Jan 3, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24